Show simple item record

dc.contributor.authorMayasari Kurnia N. D.
dc.date.accessioned2013-12-17T02:15:19Z
dc.date.available2013-12-17T02:15:19Z
dc.date.issued2013-12-17
dc.identifier.nimNIM092210101055
dc.identifier.urihttp://repository.unej.ac.id/handle/123456789/9316
dc.description.abstractABSTRAK 1-(4-nitrobenzoiloxymethyl)-5-fluorouracil were synthesized from a lead compound 5-fluorouracil (5FU), an anticancer commonly used for treating breast cancer. The compound were synthesized by two steps, the substitution of hydroxymethyl to N1 position of 5-FU followed by esterification by 4nytrobenzoilcloride. The product were purified by coloumn chromatography and identified by 1 HNMR and FTIR-KBr. The purity was characterized by TLCDensitometry and its melting point range. Finally, the compound was synthesized successfully.en_US
dc.language.isootheren_US
dc.relation.ispartofseries092210101055;
dc.subject1-4-nitrobenzoyloxymethyl-5-fluorouracil 5-fluorouracil anticancer benzoylationen_US
dc.titleSINTESIS 1-(4-NITROBENZOILOKSIMETIL)-5FLUOROURASIL SEBAGAI PENGEMBANGAN OBAT KANKERen_US
dc.typeOtheren_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record